Retrospective study methods

Antibody microrarray slides are printed and incubated with biotinylated patient serum. Levels of bound antigens are detected by fluorescence scanning. State-of-the-art machine learning algorithms were employed in the development of the IMMray™ PanCan-d signature. Hundreds of analytes were thus reduced to generate a comprehensive signature capable of distinguishing pancreatic ductal adenocarcinoma (PDAC) from controls as illustrated below.



IMMray™  microarray technology




Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form.

Press releases
Financial reports